Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass of 3,4,5-trichlorophthalic acid, strontium salt and 3,4,6-trichlorophthalic acid, strontium salt and 3,4-dichlorophthalic acid, strontium salt and 3,5-dichlorophthalic acid, strontium salt and 3,6-dichlorophthalic acid, strontium salt and 3-chlorophthalic acid, strontium salt and 4,5-dichlorophthalic acid, strontium salt and 4-chlorophthalic acid, strontium salt
EC number: 925-568-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2019-06-24 to 2019-09-10
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- adopted on 18th June 2019
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Strontium dichlorophthalate
- EC Number:
- 304-292-3
- EC Name:
- Strontium dichlorophthalate
- Cas Number:
- 94248-20-1
- Molecular formula:
- C8H4Cl2O4.Sr
- Test material form:
- solid
- Details on test material:
- Strontium phthalate (HPLC): 0.51 w/w %
Strontium 3-chlorophthalate (HPLC): 0.73 w/w %
Strontium 3,6-dichlorophthalate (HPLC) / Strontium 4-chlorophthalate (HPLC): 10.59 w/w %
Strontium 3,4-dichlorophthalate (HPLC): 20.56 w/w %
Strontium 3,5-dichlorophthalate (HPLC): 0.66 w/w %
Strontium 3,4,6-trichlorophthalate (HPLC): 0.18 w/w %
Strontium 4,5-dichlorophthalate (HPLC): 60.59 w/w %
Strontium 3,4,5-trichlorophthalate (HPLC): 4.39 w/w %
Strontium tetrachlorophthalate (HPLC): 0 w/w %
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch number of test material:Dynamit Nobel GmbH Explosivstoff- und Systemtechnik, WE50352354
- Expiration date of the lot/batch: 28 November 2019
- Purity test date: 2 May 2019
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: 5 °C – 40 °C, protected from light, separated from oxidizers, strong acids and alkalis; do not heat
- Stability under storage conditions: stable under normal conditions
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test item (25 mg) was directly applied atop the tissue
In vitro test system
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- This test uses the EpiDerm™ reconstructed human epidermis model (MatTek) which consists of normal human epidermal keratinocytes (NHEK) which have been cultured to form a multi-layered, highly differentiated model of the human epidermis and therefore the EpiDerm™ epidermis model exhibits in vivo-like morphological and growth characteristics which are uniform and highly reproducible.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm™ Standard Model (EPI-200-SIT, MatTek)
- Tissue batch number(s): Lot No.: 30807
- Date of initiation of testing: 24th June 2019
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37 ± 1 °C
- Temperature of post-treatment incubation (if applicable): 37 ± 1 °C
REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: the tissues were washed by filling and emptying the inserts 15 times with DPBS using a constant stream in about 1.5 cm distance from the tissue surface. Subsequently, the inserts were completely submerged three times in 150 mL DPBS and shaken to remove rests of the test item. Finally, the inserts were rinsed once from the inside and the outside with sterile DPBS. Excess DPBS was removed by blotting the bottom with blotting paper.
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1 mg/mL
- Incubation time: 3 h ± 5 min
- Wavelength: 570 nm
- Filter bandwidth: ± 30 nm
NUMBER OF REPLICATE TISSUES: 3
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if the tissue viability after exposure and post-incubation is less than or equal to 50%
- The test substance is considered to be non-irritant to skin if the viability after exposure and post-incubation is greater than 50% - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 25 mg
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 30 μL DPBS
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 30 μL 5% SDS solution - Duration of treatment / exposure:
- 60 ± 1 min
- Duration of post-treatment incubation (if applicable):
- 42 h post-incubation
- Number of replicates:
- 3 per dose group
Results and discussion
In vitro
Results
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- mean of three tissues
- Value:
- 86.3
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes, the mean absolute OD570 of the three negative control tissues was ≥ 0.8 and ≤ 2.8 (1.646)
- Acceptance criteria met for positive control: Yes, the mean relative tissue viability of the positive control was ≤ 20% (7.4%)
- Acceptance criteria met for variability between replicate measurements: Yes, the standard deviation of viability of replicate tissues of all dose groups was ≤ 18% (1.1%).
For detailed results see Table 1 in box "Any other information on results incl. tables".
Any other information on results incl. tables
Results of the Pre-Experiments:
The mixture of 25 mg test item per 1 mL MTT medium showed no reduction of MTT compared to the solvent. The mixture did not turn blue/purple. Therefore, NSMTT equalled 0%.
The mixture of 25 mg of the test item per 300 μL aqua dest. and per 300 μL isopropanol showed no colouring detectable by unaided eye-assessment. Therefore, NSC equalled 0%.
The test item showed no non-specific reduction of MTT and no relevant colouring potential after mixture with aqua dest. and with isopropanol. Therefore, no additional controls for correction of possible false-negative results were necessary.
Results of the main experiment:
Name |
Negative Control |
Positive Control |
Test Item |
||||||
Replicate Tissue |
1 |
2 |
3 |
1 |
2 |
3 |
1 |
2 |
3 |
Absolute OD570 |
1.716 |
1.750 |
1.419 |
0.138 |
0.171 |
0.173 |
1.368 |
1.380 |
1.487 |
1.737 |
1.803 |
1.453 |
0.160 |
0.152 |
0.193 |
1.375 |
1.469 |
1.482 |
|
Mean Absolute OD570 |
1.646**** |
0.164 |
1.427 |
||||||
OD570(Blank Corrected) |
1.669 |
1.704 |
1.372 |
0.091 |
0.125 |
0.126 |
1.321 |
1.333 |
1.441 |
1.691 |
1.757 |
1.406 |
0.114 |
0.105 |
0.147 |
1.328 |
1.423 |
1.435 |
|
Mean OD570of the Duplicates |
1.680 |
1.730 |
1.389 |
0.102 |
0.115 |
0.136 |
1.325 |
1.378 |
1.438 |
Total Mean OD570of the 3 Replicate Tissues (Blank Corrected) |
1.600* |
0.118 |
1.380 |
||||||
SD of Mean OD570of the 3 Replicate Tissues (Blank Corrected) |
0.184 |
0.017 |
0.057 |
||||||
Relative Tissue Viability [%] |
105.0 |
108.2 |
86.8 |
6.4 |
7.2 |
8.5 |
82.8 |
86.1 |
89.9 |
Mean Relative Tissue Viability [%] |
100.0 |
7.4** |
86.3 |
||||||
SD of Relative Tissue Viability [%]*** |
11.5 |
1.1 |
3.5 |
||||||
CV [% Viabilities] |
11.5 |
14.6 |
4.1 |
* Blank-corrected mean OD570 of the negative control corresponds to 100% absolute tissue viability.
** Mean relative tissue viability of the three positive control tissues is 20%.
*** Standard deviation (SD) obtained from the three concurrently tested tissues is ≤ 18%.
**** The mean absolute OD570 of the negative control i s≥ 0.8 and ≤ 2.8.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In conclusion, in this in vitro skin irritation study (OECD 439), strontium dichlorophthalate is considered to no be irritant to the skin (UN GHS “No category”).
- Executive summary:
In a primary dermal irritation study conducted according to OECD guideline 439, the EpiDerm™-Model (EPI-200-SIT) was topically exposed to strontium dichlorophthalate for 60 min and 42 h post incubation period. Irritant potential of the test item was not predicted from the relative mean tissue viabilities obtained compared to the corresponding negative control tissues concurrently treated with DPBS. The mean relative tissue viability (% negative control) was > 50% (86.3 %) after 60 min treatment and 42 h post-incubation. Therefore, the test item is not considered to be irritating to the skin in accordance with UN GHS "No Category”.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
